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Abstract
Purpose This report describes the development and validation process of an assessment with national consensus in appropriate
and safe pharmacotherapy.
Methods Aquestion-database on safe prescription based on literature of pharmacotherapy-related harmwas developed by an expert
group from Dutch medical faculties. Final-year medical students concluded a 2-year education program on appropriate and safe
prescription by one of nine assessment variants of 40 multiple-choice questions each. An expert panel of professionals (n = 10)
answered all database questions and rated questions on relevance. Questions were selected for revision based on lack of relevance or
poor test and item characteristics.
Results A total of 576 final-year medical students of the Radboud University was assessed. There was no significant difference in
performance between students and content expert group (p = 0.7), probably due to learning behavior. Out of 165 questions, 59
were selected for revision.
Conclusion Joint national effort from a team of experts in prescription and pharmacotherapy is an appropriate way to achieve a
valid and reliable last-year student drug prescription assessment.
Keywords Prescribing .Medication safety . Education
Introduction
Teaching junior doctors to be prepared to write appropriate
and safe prescriptions requires integration of knowledge on
drug selection, dosage, side effects, interactions with other
drugs, co-morbidities, and individual (genetic) variability in
pharmacokinetics. Many studies report a high rate of inappro-
priate prescribing as a potential cause of preventable morbid-
ity and mortality [1, 2]. In this light, it is relevant to note that
for the hospital setting, most drugs are prescribed by junior
doctors with limited clinical experience [3]. For example, in
the United Kingdom, half of the prescriptions were made by
foundation Y1 doctors, so the doctors with the least experi-
ence [3]. Although the cause of a prescribing error is probably
multifactorial, and related to for example time pressure or
interruptions, it is also shown that junior doctors tend to copy
the drug treatment choices of their supervisors instead of bas-
ing their choices on their own independent analysis of the [4].
One way or the other, it is prerequisite that junior doctors are
well prepared for the high-risk task of prescribing, before
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entering the ward. Therefore, sufficient education on appro-
priate and safe prescribing is conditional and an assessment on
whether this education had led to sufficient knowledge could
be recommended. On top of that, it is shown that assessments
drive the learning of the students [5]. Unfortunately, appropri-
ate learning outcomes for such an education program are lack-
ing in many (European) countries [6, 7].
It is known that the majority of adverse events are caused by a
relatively small group of drugs, i.e., pain medication (non-steroi-
dal anti-inflammatory drugs (NSAIDs) and opioids), (combina-
tion of) antithrombotics, antibiotics, cardiovascular agents, and
drugs which are renally excreted [8–12]. Experts from seven out
of eight Dutch University Medical Centers, brought together via
the Dutch Society for Clinical Pharmacology and Biopharmacy
(further referred to as ‘expert working group’), reached consen-
sus on the learning goals as shown in Table 1, based on the drugs
causing the most drug-related harm in clinical practice.
For each of these drugs, the expert working group decided
specifically what learning goals should be mastered to ensure
appropriate and safe prescribing. These included mechanism
of action, the side effects that may harm the patient, risk fac-
tors for these side effects (both patient factors and co-medica-
tion), measures to prevent these side effects, and how to act if
these side effects occur. Since drug-related harm was the
starting point, the learning goals concern mainly safety.
However, the most important indications of the drug causing
drug-related harm had to be mastered. For antibacterial drugs,
the learning goals mainly cover efficacy and not safety. The
expert working group has taken the initiative to develop an
educational program in pharmacotherapeutics which is
followed by a formal assessment of students’ comprehension
and application of knowledge on safe prescribing. On the
Blooms taxonomy on cognitive domains, learning domains
ranging from recall of information to applying and synthesis
of information should be incorporated in this educational pro-
gram and assessment on safe pharmacotherapy [13].
The educational program consists of a reader with literature
review, practice assessments, and interactive lectures, which
can be seen at https://www.youtube.com/user/fteindtoets/ (in
Dutch). For better understanding of the scope of the reader,
the learning goals for the domain of anticoagulants is added
as an e-Appendix.
After the educational program, students could obtain a
Bmedical prescribing license^ by passing the formal assessment
[14], which is part of the final-year medical examination pro-
gram. By passing this assessment, the students demonstrate a
certain basic level of mandatory knowledge for appropriate and
safe prescribing analogous to the driving license theory test.
It is the ultimate vision of the expert working group to
develop a compulsory assessment on all medical faculties in
the Netherlands, so that medical students cannot graduate if
they do not control both the knowledge and the skills needed
for appropriate and safe drug prescription. Therefore, we de-
scribe in this paper the development and validation of a formal
assessment in appropriate and safe pharmacotherapy by joint
national effort and report its external validation process by
using an independent group of experts for assessing content
validity (further referred to as Bcontent expert panel^).
Methods
This study was designed to develop and study the quality of a
newly developed 40 questions assessment on pharmacothera-
py knowledge for last-year medical students.
Development of the assessment: content
First, national consensus was achieved on the knowledge base
required for the medical students by an expert working group
(n = 7), consisting of representatives from seven out of eight
Dutch medical faculties [14]. All of the members of the expert
Table 1 Consensus-based domains for pharmacology training in last-year medical students across The Netherlands
Domains Subjects per drug-related group
Drug-related topics Analgesics 1. Medications and mechanisms of action
2. Main indications
3. Relevant kinetic data
4. Main problems or side effects: including mechanism of action and
main clinical presentation per agent
5. Patients who are most at risk per problem or side effect
6. Key interactions and mechanisms contributing to problem or side effect
7. Measures to prevent problems or side effects
8. Measures to take if a problem arises or side effect occurs
Anticoagulants
Cardiovascular agents
Drugs for diabetes mellitus
Antidepressants
Benzodiazepines
Antibiotics
General knowledge Basic pharmacokinetics
Drug allergies
Laws and regulations
Appropriate drug use
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working group were physician or pharmacist, all registered
clinical pharmacologists.
In order to design the curriculum to prepare the students for
applying the underlying knowledge in this assessment, a stepped
approach was chosen: (1) identify the drug groups which cause
most harm, (2) identify the learning goals per group, and (3)
identify additional important knowledge to be assessed.
For the first step, the expert working group identified the drug
groups known to cause the majority of preventable serious ad-
verse reaction based on the Dutch HARM-Wrestling Task Force
targeting outpatient drug safety [15]. The following drug groups
were identified and clustered by indication into seven drug-
related domains, namely, (1) analgesics, (2) anticoagulants, (3)
cardiovascular agents, (4) drugs for diabetes mellitus, (5) antide-
pressants, and (6) benzodiazepines. By consensus, the expert
working group added (7) antibiotics as domain. Antibiotics are
widely used and, in the opinion of the expert working group,
knowledge about good antibiotic practice is relevant because
injudicious use may not only cause harm in individual patients
but may also induce antimicrobial resistance at the societal level.
Second, the expert working group systematically assessed
the following categories to identify learning goals connected
to these drug groups: (1) medications and mechanisms of ac-
tion, (2) main indications, (3) relevant kinetic data, (4) main
problems or side effects: including mechanism of action and
main clinical presentation per agent, (5) patients who are most
at risk per problem or side effect, (6) key interactions and
mechanisms contributing to problem or side effect, (7) mea-
sures to prevent problems or side effects, and (8) measures to
take if a problem arises or side effect occurs.
Additionally, general knowledge domains concerning re-
lated general pharmacotherapy were defined by the expert
working group, based on expert opinion and added to the
previously defined seven drug groups, i.e., (1) basic pharma-
cokinetics including simple dosage calculations; (2) drug al-
lergies; (3) laws and regulations including medicine and
driving, and drug prescribing; and (4) appropriate drug use
consisting of topics like the WHO-six-step method [16], phar-
macotherapy in case of pregnancy, and lactation and transfer
of information to pharmacist and primary care physician.
For the final step, Table 1 shows the domains and subjects
per drug group as a result of expert consensus. Table 2 shows
the test matrix of the assessment based on these domains.
After three steps of content development, a total of 11 assess-
ment domains were identified by expert consensus: core pre-
scription knowledge on seven drug groups and on four related
general pharmacotherapy domains. For details about drugs to
be studied by the students per domain, see e-Appendix.
Development of the assessment: from questions
to assessment
The expert working group created a database of multiple-
choice questions covering basic and applied knowledge of
the selected drugs and general topics. All experts contributed
questions which were subsequently reviewed by experts from
two other medical faculties. Second, all questions were ap-
praised by an assessment expert which ultimately resulted in
a database with 165 peer-reviewed and approved questions.
Next, from this database, assessments were drawn
consisting of 40 questions each, covering the previously men-
tioned 11 domains with 2 to 6 questions per domain. In
Table 1, the number of questions per category in each assess-
ment is shown. These assessments were checked for duplicate
questions and contamination between the questions, e.g., if
one question could be helpful to answer another question. If
needed, small adjustments were made to the assessment and
questions were replaced by other questions. From the data-
base, nine different assessments were drawn, which were al-
ternately used for the test taking.
Participants and data collection procedure
In the period of March 2015 to December 2016, the assess-
ment took place monthly in groups of on average 30 final-year
medical students from the Radboud University Faculty of
Medical Sciences. In total, 576 students were assessed, during
1-h sessions. The assessments consisted of 40 multiple-choice
questions per assessment with on average four (range: two to
five) alternatives resulting in at least 150 answer options per
assessment, which is considered as lower limit for reliable
psychometric analysis.
The assessment was summative as part of their regular
curriculum; students had to pass it to become a physician.
Those who failed the assessment had to repeat the assessment
until they acquired a sufficient score. The pass rate was set at
80% correct answers after correction for guessing.
To study concurrent validity, a content expert panel,
consisting of physicians with regular prescribing activities
Table 2 Test matrix
Domains Questions (n)
Drug-related topics Analgesics 6
Anticoagulants 6
Cardiovascular agents 6
Drugs for diabetes mellitus 4
Antidepressants 4
Benzodiazepines 2
Antibiotics 4
General knowledge Basic pharmacokinetics 2
Drug allergies 2
Laws and regulations 2
Appropriate drug use 2
40
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and pharmacists, all registered clinical pharmacologists, was
composed. The experts were approached by e-mail in October
2016 with the request to participate. The goal of this content
expert panel was twofold: first to verify whether these experts
considered the questions a precondition to be able to perform
safe pharmacotherapy in clinical practice and second for ex-
ternal validation by comparison of the students’ results with
the experts’ scores. The content experts examined the full set
of 165 questions. All questions were answered and rated on
relevance by choosing Bessential,^ Buseful, but not essential,^
or Bnot necessary^ according to Lawshe [17]. Additionally,
there was an option for the expert to note comments per ques-
tion. The mean values per assessment for the experts were
reduced from the total set of 165 questions.
The answers of the students, the answers of the experts, and
experts’ relevance scores and comments were anonymously
collected and analyzed.
Data analyses
Construct validity
In order to study construct validity of the assessment as a
whole, the following analyses were performed:
Concurrent validity was studied by comparing the means
of the medical students with the experts from the content ex-
pert group by unpaired t tests for the overall comparison.
Content validity was tested according to Lawshe [17]; all
experts rated all questions as Brelevant^ (value 1) or either one
of the other two options: useful, but not essential, or not nec-
essary, and in that case scored the item as Bnot relevant^: value
− 1. If the mean score was positive, an item was scored as
Bprecondition to be able to perform safe pharmacotherapy .^
Content validity was tested with a focus on the most frequent
occurring drug-related problems, by which the larger part of
safe prescribing was tested.
Criteria for content validity, discriminant analysis and test
characteristics were combined to evaluate the appropriateness
of all items separately (see below).
Reliability
Different aspects of reliability were analyzed, namely, the in-
ternal consistence of the assessment as a whole and several
parameters per question. To start with, the internal consistency
was measured by Cronbach’s alpha [18] per assessment,
which should be 0.50 or higher, as proposed for multidimen-
sional assessments and relatively short test lengths [19, 20].
Internal consistency was only analyzed in the student group
because the internal consistency differs per test population,
and the students were the population aimed for. Next, for all
questions, discriminant analysis was performed per item cal-
culating the BDifficulty Index^with correction for guessing on
multiple choice; probability (p′), reflecting the percentage of
students who answered the item correctly, including correc-
tion for guessing (p′ = p − (1 − p) / (number of options − 1).
The scores were interpreted as follows: > 0.9: easy question,
0.9 to 0.5: medium difficulty, < 0.50: difficult question for
three-option multiple-choice questions, and for four-option
multiple-choice questions: > 0.9, between 0.9 and 0.44, and
< 0.44, respectively to correct for chance. Next, item-rest cor-
relation (Rir) was calculated, which is the correlation between
the question score and the overall assessment score (excluding
that question), referring to how well a question differentiates
between participants who master the material and those that
do not know) [21]. Rir scores were categorized as: < 0.19:
poor, 0.20–0.29: adequate, 0.30–0.39: good, and > 0.40: very
good) [22, 23]. Standard deviation was calculated for all as-
sessments for students and content expert panel as a group.
For adequate interpretation of the quality of the questions,
each question should preferably at least be used 100 times
[23]. To accomplish this, we reduced the amount of assess-
ment variants to the first four (of a total of nine). The other test
variants were used less often, and so, for the questions in these
variants, this criterion was not met.
Selection procedure of potentially inappropriate
items
Finally, potentially inappropriate questions were selected for
revision. A question was considered potentially inappropriate
if at least one of the following criteria was met; (1) difficulty
index (p′ value) < 0.8 for experts, (2) rated Birrelevant^ by a
majority of the content expert panel, or (3) p value < 0.65 for
students and item-rest-correlation ≤ 0.
All assessments were entered in the online assessment tool
TestVision (Teelen Kennismanagement, The Netherlands).
Psychometric analysis was performed with Microsoft Excel
2007 (Microsoft) and IBM SPSS 22.0 (IBM). Statistical sig-
nificance was set at p < 0.05.
Results
From March 2015 to December 2016, 576 unique stu-
dents (66% female) were assessed, as well as 10 inde-
pendent experts from the content expert panel (40%
female). The students completed a total of 673
assessments.
Table 3 shows the main results. The vast majority (87.3%)
of the students passed the assessment at the first attempt. A
total of 73 students (12.7%) had to retake the assessment
(8.9% once, 3.5% twice). The mean score of the students
was 90.5% and of the experts 90.7%.
1264 Eur J Clin Pharmacol (2019) 75:1261–1268
Validity
Three domains of validity were studied. First, the experts were
compared with the students for concurrent validity. There was
no significant difference between the students and the experts
(mean score 36.18 out of 40, (SD 2.97) versus mean 36.29
(SD 2.03) (t(761) = − 0.352, p = 0.73). Overall, the mean rat-
ing of the questions was positive meaning Bessential^ by a
majority of the experts. Still, 24.4% (n = 40) of the questions
were considered Buseful, but not essential,^ or Bnot
necessary.^ All these 40 questions were marked as potentially
inappropriate.
Reliability
First, the analysis of complete assessments was consid-
ered. Internal consistence as measured by the Cronbach
alpha (a measure of internal consistency) how closely re-
lated a set of items are as a group. It is considered to be a
measure of scale reliability ranged from 0.54 to 0.77 and
was in the range 0.5 or above per test, which is adequate
to good.
Next, discriminant analyses on the level of the individ-
ual questions were performed. The majority of the ques-
tions (87.9% (n = 145)) turned out to be easy p′ > 0.90)
based on students results. Ten questions (6.1%) were
medium and five items (3.0%) turned out to be a difficult
question. The item-rest correlation was very good for
13.9% (n = 23) of the questions, good for 16.4% (n = 27)
of the questions, adequate for 23.6% (n = 39) of the ques-
tions, and poor for 43.0% (n = 71) of the questions.
Qualitative analysis of potentially inappropriate
questions
Figure 1 showswhich questionswere included forwhat reason in
further adjustments based on potential inappropriateness. A total
of 59 out of 165 questions (36%)weremarked for revision based
on at least one of the three defined criteria; 38 questions based on
difficulty for the experts (p′ < 0.8), 40 questions based on lack of
relevancy as rated by the majority of the experts, and seven
questions based on student criterion. The vast majority of the
questions was marked for revision based on the first two criteria.
The third criterion only added one unique question to the set.
As a result of this discriminant analysis, all marked items
were revised for future use by the expert working group.
Discussion
This report describes the development of an assessment on
pharmacotherapy knowledge for medical students. Based on
Table 3 Validity and reliability of the nine assessments of 40 questions each for student and clinical pharmacology experts
Groups
Medical students n = 576 Content expert panel a n = 10
Assessment
(Qb = 40)
Tests
completed
Mean score in %
(SDc)
Mean
p′d
Item-rest
correlatione
Cronbach’s
alphaf
Mean score In %
(SDc)
Mean
p′d
p value t
test
1 131 90.80 (6.85) 0.87 0.21 0.65 91.50 (6,03) 0.88 p = 0.66
2 101 87.13 (7.10) 0.81 0.18 0.60 88.25 (3.13) 0.83 p = 0.62
3 110 92.65 (5.70) 0.90 0.25 0.54 91.75 (6.68) 0.89 p = 0.64
4 100 91.70 (7.45) 0.89 0.23 0.71 94.25 (4.73) 0.92 p = 0.29
5 65 87.80 (10.01) 0.83 0.28 0.77 90.75 (3.13) 0.87 p = 0.37
6 73 90.85 (7.48) 0.87 0.26 0.72 88.25 (4.58) 0.83 p = 0.29
7 32 90.15 (7.03) 0.87 0.29 0.68 91.75 (5.78) 0.89 p = 0.52
8 29 94.48 (5.60) 0.92 0.20 0.61 92.50 (2.63) 0.90 p = 0.29
9 32 90.00 (6.25) 0.86 0.20 0.62 87.50 (5.00) 0.82 p = 0.26
Mean assessment result 90.45 (7.05) 0.66 90.73 (4.63) p = 0.73
aA panel of physicians with regular prescribing activities and pharmacists, all registered clinical pharmacologists
b Number of questions per assessment
c Standard deviation
d p′ Difficulty Index with correction for guessing on multiple-choice items
e Item-rest correlation: index of how well a question differentiates between participants who master the material and those that do not know. (range 0.20–
0.29: adequate)
f Cronbach alpha: desired range was 0.50 or higher
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literature on frequently occurring drug-related problems,
learning goals were set by a nationwide expert working group,
resulting in 11 domains. Using a database of 165 questions,
assessments consisting of 40 questions were tested in over 500
students and 10 content experts. It appeared that the overall
performance of last-year medical students on this assessment
on appropriate and safe prescription was comparable with the
performance of experts in the field of appropriate and safe
pharmacotherapy. The assessment had an acceptable internal
consistence shown by a mean Cronbach alpha of 0.66. In the
analyses of the individual questions by the experts of the con-
tent expert panel, still, many questions should be considered
for revision namely 35.8%, with rather large overlap between
the questions as considered non-relevant by the experts and
those with low classic psychometric parameters based on ex-
pert data. This is an example of a stepwise approach of the
development of a prescribing assessment.
A relevant finding is the fact that students score near the level
of experts. Generally, summative assessments are designed to
discriminate between those who do have enough knowledge
and those who do not. The caesura, or cut of point to pass, is
adjusted depending on the mean score of the subjects tested to
assure a weighted distribution of scores independent of the diffi-
culty of the questions. In other words, a student has to be in the
upper half of scores to pass. For this assessment, however, the
national expert working group set a fixed relatively high caesura
of 80%, to be sure the students demonstrated a basic standard of
competence in safe pharmacotherapy, in analogywith the driving
license theory test. Consequently, a fair amount of 87.9% of the
questions was considered Beasy^ as measured by the easiness
index and moderate item-rest correlation index. Also, the high
caesura might have stimulated the external motivation to study
hard on this topic, with high assessment scores as a result [24].
However, whether and how these knowledge levels may again
start to differ over time during a medical career remains to be
studied [25].
More initiatives are taken worldwide to improve education
on safe pharmacotherapy and to assess pharmacotherapy
knowledge or skills [26]. For example, recently, there was a
report about a nationwide initiative for an online prescribing
Fig. 1 Diagram of items for
revision ordered by selection
criterion. Additional 52 items
selected for revision based on
expert criteria in addition to
classic test analysis criteria’ from
students’ results. aPoor
psychometric results indicating
that students who overall did
poorly on the test did better on
that item than did students who
overall did well (p value < 0.65
for students and item-rest-
correlation ≤ 0). bToo high diffi-
culty for the experts (difficulty
index: p′ < 0.8), cLack of relevan-
cy as rated by the majority of the
content expert panel
1266 Eur J Clin Pharmacol (2019) 75:1261–1268
assessment for final-year medical students in the UK, pub-
lished by Maxwell et al. [27]. However, a widely accepted
consensus is lacking on (1) the optimal strategy in education
of future prescribers to reduce prescription errors in primary
care and hospitals and (2) appropriate learning goals for this
education program and concluding assessment. This study
shows how a national collaboration can lead to a nationally
accepted assessment, which will gradually be introduced in all
medical faculties in the Netherlands.
Despite consensus in the expert working group who initial-
ly developed the assessment, it was surprising that there was a
lack of consensus between the experts that designed the as-
sessment and the content expert panel as used in this study for
external reference. This content expert panel rated 24.2% of
the individual questions as non-relevant though these ques-
tions were developed by expert colleagues. Since prescribing
is a complex skill, this often results in more than one adequate
prescription and in more than one correct answer for a clinical
problem, depending on the circumstances. This lack of con-
cordance between the expert working group and the content
expert panel is a clear indication that context affects
assessment.
The assessment in this study shows to be a valid and
reliable assessment on pharmacotherapy knowledge for
medical students. However, before nationwide application,
some considerations should be taken into account. One
could discuss whether the Cronbach’s alpha is high enough.
Although it is certainly acceptable, for an assessment with
such a high caesura of 80%, a higher alpha may be required.
The moderate alpha level may be explained by the fact that
these assessments had (1) many knowledge domains, (2)
relative limited number of items per assessment, and (3) a
rather uniform performance of the group or ceiling effect
due to learning behavior [20]. All three aspects however
were chosen as a part of the design and therefore higher
Cronbach’s alpha will probably not be obtained as long as
students intensively study for their assessment, which is
aimed for. An alternative would be to extend the assessment
by adding more questions [19]. Since the end of data inclu-
sion for this study, the assessment is extended to 60 ques-
tions per assessment. Regarding the item-analyses, it would
have been preferable to have had more assessments in the
analysis. The student numbers however were set, and with-
in the time frame of the study, more assessments were not
possible.
It should be noted that the development of this assess-
ment is the result of a nationwide Dutch collaboration.
However, because of differences in laws, regulations, and
guidelines, learning goals are not one-on-one transferable
to other countries. Nevertheless, we believe that the pro-
cedure described here, with joint national effort from a
team of experts in the field, may be feasible for imple-
mentation in other countries.
Conclusions
This study describes a valid and reliable assessment, devel-
oped by national effort to assess final-year medical students’
comprehension and application of knowledge on appropriate
and safe prescribing. With a high cut-off point to pass, stu-
dents seem to be very motivated to pass. After an education
program on appropriate and safe prescribing, students
achieved a score comparable to experts in the field. In analogy
of the Bdriving licence theory test^ an addition practical test
Bon the road^ should be obligate: this should assess whether
students can apply clinical pharmacology knowledge in clin-
ical practice.Whether such an assessment ultimately improves
safe prescription and overall patients’ outcomes has yet to be
investigated.
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STUDY HIGHLIGHTS
What is the current knowledge on the topic?
• Inappropriate prescribing leads to medication-related morbidity and
mortality
• Education is a possible tool to reduce medication-related morbidity
and mortality
What question did this study address?
• What is a feasible method to identify learning goals and content
development of an education program concluded by a pharmacotherapy
assessment in order to improve safe prescribing by future doctors in
primary care and hospitals?
What does this study add to our knowledge?
• Joint national effort from a team of experts in the field of prescription
and pharmacotherapy is an appropriate way to achieve a valid and reliable
assessment.
•By passing this assessment, students demonstrate to have knowledge
which is a perquisite for safe prescribing (at a level comparable to the
performance of experts in the field).
How might this change clinical pharmacology or translational
science?
• We describe a method which could be internationally used as a
feasible starting point in the development of a Blicense to prescribe.^
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